Hong Kong-listed biopharmaceutical stocks strengthened again in the afternoon, with Rongchang Biopharma (09995.HK) rising more than 20%, Zai Lab (09688.HK) rising more than 10%, Junshi Biosciences (01877.HK) and BeiGene (06160.HK) rising more than 7%, Kelun Biotech (06990.HK) rising more than 6.5%, and WuXi AppTec (02359.HK) rising more than 5%.

2025-06-12 13:20:10

BeiGene WuXi AppTec

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    U.S. Household Debt Hits Record High — What That Means for Markets & Consumer Risk
                            2025-12-12

                                    Even $300 K Earners Are Living Paycheck-to-Paycheck — And What That Means for Markets
                            2025-12-06

                                    Elon Musk Predicts “Work Will Be Optional” in 10-20 Years — What It Means for Markets & Options Traders
                            2025-12-09

                                    Data-Center Boom Lifts Construction Pay to Six Figures — What It Means for Real-Estate, Labor & Market Risk
                            2025-12-09

                                    Most Americans Don’t Believe Their Kids Will Be Better Off — Why That Matters for Consumer Demand & Market Sentiment
                            2025-12-09